Company intelligence / Profile preview

Medlinker

Chengdu, Sichuan, Chinaweb.medlinker.com ↗

Ownership: Private
Development stage: Commercial

Overview

Medlinker operates a large-scale digital health ecosystem focused on chronic disease management and professional collaboration. It offers an AI-powered "digital hospital," telemedicine services, online consultations, and educational resources for healthcare professionals. The company has established partnerships with hospitals and biopharma companies such as Gilead Sciences to explore direct-to-patient solutions for conditions like Hepatitis C. Its technology stack includes artificial intelligence for diagnostics/personalization and blockchain for data security. The company has expanded internationally beyond China.

Therapeutic areas: Other
Industry: Non-Academic Healthcare

Partnerships

Gilead Sciences (collaboration on direct-to-patient solutions for Hepatitis C)

Beyond the preview

Go deeper on Medlinker.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medlinker.

Explore the full profile